127 related articles for article (PubMed ID: 3003808)
1. Variability of chronic antidepressant treatments on beta-adrenergic receptor sites.
Suranyi-Cadotte BE; Dam TV; Bodnoff S; Quirion R
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):765-8. PubMed ID: 3003808
[TBL] [Abstract][Full Text] [Related]
2. Rapid changes in central beta-adrenergic receptors after chronic intravenous infusion of antidepressants.
Sethy VH; Day JS; Cooper MM
Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):35-46. PubMed ID: 3025979
[TBL] [Abstract][Full Text] [Related]
3. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
Ferris RM; Beaman OJ
Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent down-regulation of beta-adrenergic receptors after chronic intravenous infusion of antidepressants.
Sethy VH; Day JS; Cooper MM
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):673-82. PubMed ID: 2851860
[TBL] [Abstract][Full Text] [Related]
5. [Desipramine-induced down regulation of beta-adrenergic receptors: effects of noradrenergic and serotonergic neuronal activities and of alpha 2-adrenergic receptor mediated mechanisms].
Matsubara S
Hokkaido Igaku Zasshi; 1987 Mar; 62(2):301-10. PubMed ID: 3038720
[TBL] [Abstract][Full Text] [Related]
6. [Antidepressant drugs and central monoaminergic receptors].
Asakura M; Tsukamoto T
Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
[TBL] [Abstract][Full Text] [Related]
7. Functional supersensitivity to the alpha 1-adrenoceptor agonist after repeated treatment with antidepressant drugs is not conditioned by beta-down-regulation.
Mogilnicka E; Zazula M; Wedzony K
Neuropharmacology; 1987 Oct; 26(10):1457-61. PubMed ID: 2891072
[TBL] [Abstract][Full Text] [Related]
8. Rapid decrease in rat brain beta adrenergic receptor binding during combined antidepressant alpha-2 antagonist treatment.
Scott JA; Crews FT
J Pharmacol Exp Ther; 1983 Mar; 224(3):640-6. PubMed ID: 6131122
[TBL] [Abstract][Full Text] [Related]
9. In vitro modulation of CNS beta-receptor number by antidepressants and beta-agonists.
U'Prichard DC; Enna SJ
Eur J Pharmacol; 1979 Nov; 59(3-4):297-301. PubMed ID: 43257
[TBL] [Abstract][Full Text] [Related]
10. [Effects of lithium and antidepressants on monoaminergic receptors and receptor-coupled adenylate cyclase system in rat brain].
Odagaki Y
Hokkaido Igaku Zasshi; 1992 Mar; 67(2):247-58. PubMed ID: 1317819
[TBL] [Abstract][Full Text] [Related]
11. Modulation of rat brain alpha 2- and beta-adrenergic receptor sensitivity following long-term treatment with antidepressants.
Asakura M; Tsukamoto T; Hasegawa K
Brain Res; 1982 Mar; 235(1):192-7. PubMed ID: 6329413
[TBL] [Abstract][Full Text] [Related]
12. Behavioral effects of beta adrenergic agonists and antidepressant drugs after down-regulation of beta-2 adrenergic receptors by clenbuterol.
O'Donnell JM
J Pharmacol Exp Ther; 1990 Jul; 254(1):147-57. PubMed ID: 1973194
[TBL] [Abstract][Full Text] [Related]
13. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
Riva MA; Creese I
Mol Pharmacol; 1989 Jul; 36(1):211-8. PubMed ID: 2546051
[TBL] [Abstract][Full Text] [Related]
14. Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat.
Assie MB; Charveron M; Palmier C; Puozzo C; Moret C; Briley M
Neuropharmacology; 1992 Feb; 31(2):149-55. PubMed ID: 1313158
[TBL] [Abstract][Full Text] [Related]
15. Effects of the novel antidepressant S-adenosyl-methionine on alpha 1- and beta-adrenoceptors in rat brain.
Cohen BM; Stramentinoli G; Sosa AL; Babb SM; Olgiati V
Eur J Pharmacol; 1989 Nov; 170(3):201-7. PubMed ID: 2559855
[TBL] [Abstract][Full Text] [Related]
16. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.
Ordway GA; Gambarana C; Tejani-Butt SM; Areso P; Hauptmann M; Frazer A
J Pharmacol Exp Ther; 1991 May; 257(2):681-90. PubMed ID: 1674532
[TBL] [Abstract][Full Text] [Related]
17. Biochemical effects in rats after acute and long-term treatment with clovoxamine.
Bradford LD; Tulp MT; Schipper J
Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):188-202. PubMed ID: 2820327
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic mechanisms of action of antidepressants.
Frazer A; Conway P
Psychiatr Clin North Am; 1984 Sep; 7(3):575-86. PubMed ID: 6091070
[TBL] [Abstract][Full Text] [Related]
19. Effects of combined administration of L-tryptophan and tricyclic antidepressants on alpha 2- and beta-adrenoceptors and monoamine levels in rat brain.
Russell VA; Lamm MC; de Villiers AS; Taljaard JJ; Chalton DO
Neurochem Res; 1985 Dec; 10(12):1661-71. PubMed ID: 3003616
[TBL] [Abstract][Full Text] [Related]
20. Decreases in tyrosine and p-hydroxyphenylglycol caused by various antidepressants.
Edwards DJ; Sorisio DA; Sedlock ML
Biochem Pharmacol; 1988 May; 37(10):2069-75. PubMed ID: 2837224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
